Optimal Pharmacotherapy for Schizoaffective Disorder
Categories:
Department of Psychiatry ,
Best Practices in Schizophrenia Treatment (BeST) Center ,
Department of Psychiatry | Tags:
active comparator ,
adherence ,
adjunct ,
adjunctive ,
adjunctive treatments ,
antidepressants ,
antipsychotics ,
aricept ,
aripiprazole ,
carbamazepine ,
CARS-M ,
chlorpromazine ,
clinical trials ,
clinician administered rating scale for mania ,
combination antipsychotic medications ,
combination therapy ,
comedication ,
consensus schizoaffective disorder ,
continuation trial ,
depression ,
divalproex ,
dose ,
double blind ,
drug ,
Dugan ,
efficacy ,
first line treatment ,
fixed dosing ,
flexible dosing ,
haldol ,
haloperidol ,
HAM-D ,
hamilton rating scale for depression ,
hospitalization ,
how to treat schizoaffective disorder ,
injection ,
LAI ,
lithium ,
long acting injection ,
maintenance treatment ,
mania ,
medication ,
medication trials ,
medications for schizoaaffective disorder ,
medicine ,
monotherapy ,
mood stabilizer ,
mood stabilizers ,
non-adherence ,
off-label ,
olanzapine ,
paliperidone ,
paliperidone palmitate ,
PANSS ,
pharmacologic treatment ,
pharmacology ,
pharmacotherapy ,
placebo ,
placebo controlled ,
polypharmacy ,
positive and negative syndrome scale ,
psychosis ,
psychotic disorder ,
psychotic symptoms ,
randomized trial ,
relapse ,
relapse prevention ,
retrospective exploratory analysis ,
risperdal ,
risperidone ,
sad ,
Sara ,
Sara Dugan ,
schizophrenia ,
treatment ,
trial ,
untreated psychosis ,
valproate ,
valproic acid
VIDEO
In this lecture, Dr. Dugan discusses medications that might be useful in treating schizoaffective disorder. By the end of this lecture, you will be able to: 1) describe the pharmacotherapeutic medications used for the treatment of schizoaffective disorder (SAD) and 2) compare the efficacy and safety data of different medications for the treatment of patients with SAD.